PhysioLogic Devices’ management team represents decades of professional experience in all aspects of Type 1 Diabetes.

Peter Lord, Chief Executive Officer and Founder

Pete has dedicated his entire engineering career to the development of progressively more sophisticated external and implantable insulin pumps. He was the lead engineer for the development of a series of implantable insulin pumps, beginning with the PIMS (Programmable Implantable Medication System) series and continuing through to the MIP 2001 (MiniMed Implantable Pump) series and ultimately the MIP 2007D, the only existing implantable insulin pump, which has benefitted hundreds of devoted patients. Pete is widely recognized as a world leader in the development of implantable medical devices. His stellar reputation in the field has allowed PhysioLogic Devices to attract a team of engineers with rare decades-long experience in the development of implantable insulin pumps. Pete has successfully headed regulatory, research and development, and clinical research teams throughout his career. His dedication to improving the lives of those living with Type 1 diabetes inspired him to found PhysioLogic Devices, with the aim of creating the first truly autonomous blood glucose management system. 

Christian Merot, Chief Operating Officer

Christian began his career researching fluid dynamics of advanced torpedoes, then moved to commercial enterprises involving hardware systems. Initially, he focused on developing and manufacturing ultra-precision machinery, becoming proficient in exacting design and manufacturability.  While at 3D Systems, he coined the phrase “additive manufacturing”, co-led the implementation of world-class manufacturing capabilities, and developed an efficient release-to-production process. Christian later joined the Al Mann Foundation as a critical member of Pete Lord’s team, tasked with developing an implantable infusion drug pump delivering intrathecal medication for pain management. He spearheaded the effort to redesign and develop novel manufacturing methods, resulting in a robust pump mechanism which met highly specific performance and yield requirements. Additionally, he has co-led a feasibility study of drug delivery to targeted brain tissue by an implantable infusion drug pump and was responsible for the development of a quality management system for two medical device companies. Christian brings to PhysioLogic Devices a strong background in manufacturing principles, quality management systems, medical device regulations, and the development of Class III implantable infusion drug pumps, and he is passionately committed to helping us achieve our mission.

Gerda Resch, Director of Regulatory Affairs and Quality Assurance

Gerda’s extensive experience in regulatory affairs, with an emphasis on medical devices in both Europe and the United States, provides PhysioLogic Devices with the critical capability to successfully navigate this complex arena. Gerda has worked with Medtronic, Baxter, Ioptex, Alfred Mann Foundation and MiniMed, and has extensive experience in quality control, microbiology, OTC drug regulation and process improvement. Gerda has been certified as an ISO 9001 assessor, an ASQ quality auditor, biomedical auditor and in-house auditor. Her responsibilities have included internal auditing, quality systems, international and domestic medical devices, biologics and combination product submissions, CE marking, risk management, regulatory compliance, handling complaints, labeling and import-export. In the field of distribution support, she has held the position of authorized designated pharmacy representative, with verified authorized wholesale distributor oversight (National Association of Boards of Pharmacy) and distribution licensing. Gerda’s experience with the implantable insulin pump began in the 1990s with the introduction of the model MIP 2001 in the United States and Europe.